Apologies to all readers who may have jumped on the CSL train in the past 5 years due to Slack Investor continually ‘bigging up’ this grand old stock. He has always been impressed with companies that spend a good portion of their profits in Research and Development.
‘CSL have committed to spending 10% of global revenue on R&D for new and existing products.’ –Livewire
Slack Investor has been a holder of this company since the ‘good old days’ (before 2020). But has occasionally topped up when the price dipped below $300. So, he does share some of the recent pain.
The latest price slump was on the back of the FY 2025 results and the announcement that one of CSL’s components, CSL Seqirus, was to be demerged. The markets were not that impressed with the planned restructure and slowing growth momentum.
However, some sectors of the business are doing well. CSL Behring and CSL Vifor reported strong growth.
This CSL horse should have some good riding ahead
The 2025 AGM indicated that management were taking the knife to costs and staff in a restructure of the business that is underpinned by the Seqirus spinoff and $500 million in pre-tax savings.
‘Despite all the headwinds from competition and regulatory price cuts, they’re (CSL) still growing double digit. I think that’s a pretty good business.‘ Daniel Moore – IML, reported in Livewire
When nervous … Slack Investor will always go back to the numbers. Market Screener – Finance Tab for CSL supplies some of the answers. The Income chart looks healthy.
Income (Black) and projected income (Striped Grey) for CSL – Market Screener
Looking at the projected PE, ROE and growth from Market Screener – future predictions look OK.
Another wild month. The S&P 500 (+3.5%) and the FTSE 100 (+1.8%) remain in all time high territory. The ASX 200 sputtering and down 1.4% for the month.
Slack Investor remains IN for all markets.
The recent strength of the US market has pushed the closing monthly value to more than 15% above my old stop loss. I adjusted the stop loss upwards to a new ‘higher low’ of 6212 for the S&P 500.
All Index pages and charts have been updated to reflect the monthly changes – (ASX Index, UK Index, US Index).
The quarterly updates showing the current holdings and cash position of the Slack Portfolio have also been completed.
(in Greek tragedy) an excess of ambition, pride, etc, ultimately causing the transgressor’s ruin.
Slack Investor possesses all the human frailties – try as he might, even after decades of investing, some of these failings will occasionally surface. Recently flushed with pride with his good performance figures for the past 15 years, he let a few stock plunges go too far – on the mistaken premise that the market will quickly correct itself to reinforce Slack Investor’s view of the world.
A bit of history here … Slack Investor is disciplined in his investing in many ways. However, a trait that he struggles to shake is the sin of hubris. So convinced is Slack Investor of his magnificent stock picking abilities – he sometimes will persuade his inner self that, after a stock price fall, the ‘market’ has got this one wrong! He was so happy while his healthcare stock prices were going up that he brushed aside the unmistakable signs of decline over the past 6 months.
Slack Investor waded into Telix Pharma last year on the strength of its very impressive projected growth figures which led to a very high Slack Factor score. What he didn’t account for is the huge effect of any regulatory problems on potential growth. During reporting season, just the suggestion of problems with the regulators causes great panic.
The Telix share price plunged 18.8% on the day after the company revealed it had run into a snag with the United States Food and Drug Administration (FDA). – From Motley Fool, reporting on just one of the TLX shocks that has led to a 30% stock price drop in August 2025.
With hindsight, Slack Investor wishes he had acted more quickly with his stop loss levels, but the falls were so dramatic that only the day traders would be able to get out with some dignity. Slack Investor is not a day trader and looks at his stocks weekly.
What to do about Telix now?
The FDA concerns with TLX were about some future products in the pipeline and the actual 2025 reporting season results were quite good – hopefully, all the bad news is already priced in! It is time to rationally have another look at the stock to decide whether to dump TLX and look for other opportunities. I go to the Market Screener Finance tab for TLX.
Slack Investor first looks at the Income/Projected Income chart to ensure that the income over the past few years and the projected income are showing a rising trend. The next chart down is the Balance sheet. He is looking for debt levels that are well covered by sales. No red flags here.
He then collects a few numbers. PE levels at 170 (December 2024) are frighteningly high … but, if the projected sales growth comes to fruition, the predicted 2027 PE Ratio is a more comforting 21.
A look further down the financial page reveals the predicted profitability (ROE). The forecast ROE for 2027 is a healthy 21.53%. Further down on the page is the predicted Earnings Per Share (EPS). Slack Investor is interested in how these earnings are predicted to grow. For 2025, 2026 and 2027, the forecast EPS growth is 26.04%, 97% and 91.62%
Combining all this data together with other healthcare stocks in my portfolio that had big falls over the past few months helps me determine whether to hold onto these stocks – or not!
Where, PE (2027/28) is the forecast P/E Ratio for 2027/28; ROE (2027/28) is the forecast ROE for 2027/2028); EPS Growth is the forecast EPSG for the next three years (EPSG AV). The Slack Factor is a combination of these metricsusing the formula defined in previous posts.
Lessons?
‘Markets can remain irrational longer than you can remain solvent‘– John Maynard Keynes
There is no doubt that Slack Investor should have parked his hubris and let his healthcare stocks go at a much earlier stage in their decline – but for all sorts of human reasons, Slack Investor has found this very hard to do.
However, we are here now … and what should he do? Would he buy these stocks now at the current price? Given these forecast growth figures above … probably! So, for now, I’m being patient and hanging on.
Healthcare stocks often seem to have heroic growth estimates that are easily thwarted for regulatory reasons or the efficacy of competing products. These forecast growth figures can distort simple measures like the Slack Factor.
Mental note to Slack Investor … weather this crisis … and then, reduce exposure to speculative healthcare stocks.
A WordPress AI generated weird image that reassuringly does not make any physical sense.
Reporting Season
During February, most companies report on their progress up to the end of December. There is a similar reporting season in August for the period up to 30 June. Once all the analyst projections for future earnings are in, it is a good time to update the state of play for companies in the Slack Portfolio.
It took a while for Slack Investor to understand that a company could come in with a great report on the business and still, the price of the shares might go down. This is because reporting season is all about expectations. If a company was expecting an increase in earnings of 22% – and they ‘only’ achieved 20%, the share price is likely to get knocked down on the announcement.
As the Slack Portfolio consists of mostly growing stocks with a relatively high Price to Earnings Ratio. The growing stocks usually have high prices as the company’s growth is priced in. These stocks can get punished severely when an earnings target is missed – price falls of 10-20% are not uncommon. But, it is long term results that really count and Slack Investor is willing to endure any short-term pain for a growing company. This period of ‘Trumpenomics’ is an example of such a time.
Slack Investor uses the excellent Market Screener site (requires email registration) to get information from the Financials tab for each company. Analyst information is not available for ETF’s so, only data on the individual companies that are in the Portfolio is gathered.
In the table below, information is listed for the forecast P/E Ratio (PE 2027), the forecast Return on Equity (ROE 2027), the forecast Earnings Per Share Growth (EPSG 2025) (EPSG 2026) (EPSG 2027) and the average of the three Earnings Per Share Growth figures (EPSG AV). There is some fudging of the figures as some of the forecast EPSG figures were unavailable. Also, for some of the companies that are new to profit, their EPSG figures are skewed – I have limited the EPSG (AV) to a maximum of 50. I have ranked the companies in order according to their Slack Factor.
The Slack Factor
What is the Slack Factor? It is well known that Slack Investor likes
Profitability – measured in terms of the forecast Return on Equity – ROE 2027
Growth – measured as the average forecast Earnings Per Share Growth – EPSG (AV) for the three years 2025, 2026 and 2027.
It is well known that Slack Investor does notlike
High Price to Earnings Ratios – measured in terms of the forecast Return on Equity – PE 2027. Sometimes, great companies are just too expensive.
ROE is the forecast ROE (ROE 2027), EPSG is the forecast EPSG for the next three years (EPSG AV) and, PE Ratio is the forecast PE Ratio (PE 2027).
So, things he likes go on the top line and the things that he doesn’t like go on the bottom line. This reduces a lot of the complicated information in Slack Investor’s tiny brain to one number. He has made no attempt to scale (normalise) each input into the Slack Factor. It is just a simple way to rank companies with qualities that he thinks are good. The bigger the number, the more likely the company has attributes that Slack Investor likes – profitability, growth and a price tag that is not too expensive. With these traits … surely good things are more likely to happen?
The fast growing Telix Pharmaceuticals (TLX) is a company that Slack Investor is a fan of, and it has a high Slack Factor of 52. The growth dullard Commonwealth Bank (CBA) has a Slack Factor of only 3 – and, is of no interest to Slack Investor.
Name
Symbol
PE 2027
ROE 2027
EPSG 2025
EPSG 2026
EPSG 2027
EPSG (AV)
SLACK FACTOR
Telix Pharmaceuticals
TLX
25
26
230
70
30
50
52
REA Group
REA
40
32
98
11
17
42
34
Codan
CDA
19
23
20
23
18
20
25
Alphabet (US)
GOOGL
15
25
12
14
16
14
23
Supply Network
SNL
29
38
23
14
15
17
23
Megaport
MP1
50
19
-9
160
40
50
19
Pro Medicus
PME
115
53
40
42
30
37
17
WiseTech Global
WTC
42
20
32
38
34
35
17
Technology One
TNE
48
34
18
20
19
19
13
CSL
CSL
20
18
12
15
16
14
13
Goodman Group
GMG
18
11
34
12
20
12
Coles Group
COL
18
32
-2
17
5
7
12
RPM Holdings
RUL
38
18
10
25
40
25
12
XRF Scientific
XRF
20
18
17
11
11
13
12
CAR Group
CAR
28
15
35
18
12
22
12
ResMed
RMD
20
23
9
10
11
10
12
Wesfarmers
WES
24
33
3
13
9
8
11
Nick Scali
NCK
15
29
-28
29
14
5
10
Cochlear
COH
34
25
15
7
16
13
9
Macquarie Group
MQG
15
13
6
18
8
11
9
Botanix Pharma
BOT
Not
Ranked
–
Not
Enough
Info
Over the next quarter, I will try and sell some of the Slack Investor owned companies with a relatively low Slack Factor – and invest more in those with a high Slack Factor. For homework, using Market Screener, try to work out the Slack Factor for some of the companies in your own portfolio.
March 2025 – End of Month Update
The current ‘Trump Slump’ in stock prices can be attributed to the largest upheaval to global trade since the Second World War – Thanks Donald! All followed markets fell this month. The ASX 200 down 4.0%, the FTSE 100 down 2.6%, and the S&P 500 down 5.8%. For now, each Index remains above their stop losses. Slack Investor remains IN for the FTSE 100, the ASX 200, and the US Index S&P 500.
Slack Investor took the opportunity to tighten up his stop loss values for the FTSE 100 and the ASX 200. On the UK Index chart below, by drawing a black wavy line under the monthly minimum values, it can be seen that some new ‘higher lows’ have been established. It made sense to move up the stop loss to the most recent ‘higher low’.
All Index pages and charts have been updated to reflect the monthly changes – (ASX Index, UK Index, US Index). The quarterly updates to the Slack Portfolio have also been completed.
Dramatic falls in a stock price … are not very nice. However, they are part of the game when investing in growth stocks. These falls usually come during reporting season. This is sometimes known as ‘confession season’.
ASX-listed companies are all required to report their earnings within two months of June 30 and December 31. The half-year reports are usually floated into the market during August and February – and this is the main time that the confessions come in. ASX companies can also give quarterly updates and, they are strictly bound by ‘Continuous Disclosure’. This is where they are obliged to promptly announce any new information that may affect the stock price.
Once an entity becomes aware of any information concerning it, that a reasonable person would expect to have a material effect on the price, or value of the entity’s securities, the entity must immediately tell ASX that information – ASX Continuous Disclosure Guide
When bad news comes in, there will be an announcement and there is usually a fall in stock price. Most of the time, bad news comes in the form of an earnings forecast not being met – an earnings downgrade. It is time for Slack Investor to get off the couch.
Slack Investor is not a ‘Day Trader’ and, also Slack! This means that he doesn’t get wind of a dramatic fall in one of my holdings till the end of the day. Sometimes it is even days after the event.
This gives him time to think about what to do next, and there are two schools of thought.
Accept the loss and sell the stock to employ your funds elsewhere – as bad news often comes as a series.
Reassess the numbers on the company and ask ‘Would you invest in this company today at the current price?‘
Experience tells Slack Investor that he is usually better off with option 1 – and investing the proceeds with a, hopefully, price increasing stock.
Recent Case Studies from the Slack Investor Rogue File
This was a sudden fall from grace as it was bought in August 2024. There was an earnings downgrade and it was an easy decision to get out – as no ‘love’ had been developed for the company. Slack Investor was wrong on his understanding of this companies earnings growth.
Webjet (WEB,WJL)
This is a complex one. Slack Investor recently bought Webjet (WEB) at around $9 on the basis of their fast growing internet business WebBeds – and its seemingly good projected numbers. In September 2024, Webjet went through a demerger that split the business into its retail Travel Agent (Webjet Group – WJL.ASX) and its global Business to Business booking site, mostly WebBeds, (WEB Travel Group – WEB.ASX). Webjet announced a profit warning on 14th October and the share price plummeted 35% in a day. Whoops!
Slack Investor planned to sell WJL, the retail travel agent part of the business (not a high growth sector), and keep the growing (+22% CAGR) demerged WebBeds (WEB). This might be a good business one day – but the big 35% drop spooked him and he sold them both for a combined price of $4.80. Ouch!
Slack Investor thinks this is a good growing business but they had some revenue shortfalls that caused a 19% 1-day price drop in 2022. He probably should have got out then. However, he has grimly stuck with them and, after 2 years of falling stock prices, they seem to be on the right track. It remains in his portfolio.
After a 16% fall in a day in May 2024, Slack Investor reassessed the numbers on this stock – a projected 2026 PE of 16 and an ROE of 39%. The numbers looked pretty good – and he held on. However, the last two years of revenue growth have been 2% and 4% respectively. Slack Investor is not sure what is going on … but this company has not been growing. He sold at $8.69 this week.
Taking a loss … and moving on
This is a real skill – that doesn’t come easily – but is essential for managing a portfolio of growth stocks. Slack Investor is better at this than he used to be. Usually, growth stocks will come with a high Price/Earnings ratio as the future earnings growth will be factored into the price of the stock. These type of companies are particularly susceptible to a rapid decline in price when bad news emerges that might affect future earnings.
“Some people automatically sell the ‘winners‘— stocks that go up— and hold on to their ‘losers‘— stocks that go down— which is about as sensible as pulling out the flowers and watering the weeds” – Peter Lynch – One Up On Wall Street
Slack Investor tries to adhere to the Peter Lynch philosophy when tending to his garden of stocks. He doesn’t always get these decisions right – but he does find it ‘cleansing’ to get rid of the bad performers. With experience, he has found that, more often than not, if there is a dramatic 1–2 day fall in a stock price (>15%) – it often takes a while to recover! Slack Investor is usually happy to take the loss and move his funds elsewhere. There is ‘opportunity cost’ in staying with a stock that is going nowhere.
Despite these bad performers, he doesn’t beat himself up about them. It is just part of investing. He takes solace that his whole portfolio is up about 8% in the 4 months of this financial year – and he does have good long-term results.
With the money raised from selling the dud investments, he bought into quality earnings with half the proceeds topping up his Supply Network (SNL) holding. The rest went into a new stock that he has been watching for a while – the logistics software business WiseTech (WTC).
The company had a price drop over a saucy scandal involving the founder and CEO Richard White. He resigned and Slack Investor is betting that these private-life dalliances should not interrupt the fine profitability (ROE 2026 20%) and established revenue growth (1-yr 2024 CAGR 20%) of this great Australian company.
Slack Investor is IN for Australian index shares, the US Index S&P 500 and the FTSE 100.
All markets drifted down slightly. As many of the big market crashes have occurred in September and October, Slack Investor is always relieved to get past this time of year.
For October, the ASX 200 (-1.3%), the FTSE 100 (-1.5%) and the S&P 500 (-1.0%).
All Index pages and charts have been updated to reflect the monthly changes – (ASX Index, UK Index, US Index).
